Reuters logo
13 天前
BRIEF-Aeglea BioTherapeutics reports Q2 loss per share $0.47‍​
2017年8月9日 / 晚上8点23分 / 13 天前

BRIEF-Aeglea BioTherapeutics reports Q2 loss per share $0.47‍​

Aug 10 (Reuters) - Aeglea BioTherapeutics Inc-

* Aeglea BioTherapeutics provides corporate update and reports second quarter 2017 financial results

* Q2 revenue $1.5 million versus I/B/E/S view $1.3 million

* Aeglea BioTherapeutics - qtrly loss per share $0.47‍​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below